Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Stanford Univ Med Ctr
mi
from
Stanford, CA
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
IMMUNOe International Research Center
mi
from
Centennial, CO
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
IMMUNOe International Research Center
mi
from
Centennial, CO
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Michigan Institute for Neurological Disorders
mi
from
Farmington Hills, MI
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Michigan Institute for Neurological Disorders
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Washington University
mi
from
Saint Louis, MO
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Multiple Sclerosis Center of North Eastern New York
mi
from
Latham, NY
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Multiple Sclerosis Center of North Eastern New York
mi
from
Latham, NY
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
OMRF Multiple Sclerosis Center of Excellence
mi
from
Oklahoma City, OK
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
OMRF Multiple Sclerosis Center of Excellence
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Swedish Medical Center
mi
from
Seattle, WA
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Raleigh Neurology Associates PA
mi
from
Raleigh, CA
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Raleigh Neurology Associates PA
mi
from
Raleigh, CA
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated:  4/14/2016
London Health Sciences Centre
mi
from
London,
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Status: Enrolling
Updated: 4/14/2016
London Health Sciences Centre
mi
from
London,
Click here to add this to my saved trials
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
A Phase 2a, Open-Label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Orally Administered SNC-102 in Subjects With Tourette Syndrome
Status: Enrolling
Updated:  4/14/2016
Rush University Medical Center
mi
from
Chicago, IL
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
A Phase 2a, Open-Label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Orally Administered SNC-102 in Subjects With Tourette Syndrome
Status: Enrolling
Updated: 4/14/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
A Phase 2a, Open-Label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Orally Administered SNC-102 in Subjects With Tourette Syndrome
Status: Enrolling
Updated:  4/14/2016
North Shore University Hospital, Dept. of Psychiatry
mi
from
Manhasset, NY
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
A Phase 2a, Open-Label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Orally Administered SNC-102 in Subjects With Tourette Syndrome
Status: Enrolling
Updated: 4/14/2016
North Shore University Hospital, Dept. of Psychiatry
mi
from
Manhasset, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Cullman, AL
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Cullman, AL
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Pheonix, AZ
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Pheonix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
San Diego, CA
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Bradenton, FL
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Orlando, FL
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Lexington, KY
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
New Bedford, MA
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
New Bedford, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Detroit, MI
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Chesterfield, MO
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Rochester, NY
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Charlotte, NC
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Columbus, OH
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Charlotte, SC
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Charlotte, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Roanoke, VA
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated:  4/14/2016
mi
from
Pleven,
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis
Status: Enrolling
Updated: 4/14/2016
mi
from
Pleven,
Click here to add this to my saved trials
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
Status: Enrolling
Updated:  4/14/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
Status: Enrolling
Updated: 4/14/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Investigation of Neuroserpin as an Autism Candidate Gene
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated:  4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Investigation of Neuroserpin as an Autism Candidate Gene
Investigation of Neuroserpin as an Autism Candidate Gene
Status: Enrolling
Updated: 4/18/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  4/18/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 4/18/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  4/18/2016
Johns Hopkins University
mi
from
Baltimore, MD
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 4/18/2016
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  4/18/2016
Massachusetts General Hospital
mi
from
Charlestown, MA
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 4/18/2016
Massachusetts General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated:  4/18/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Status: Enrolling
Updated: 4/18/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Motor Learning in Stroke
Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke
Status: Enrolling
Updated:  4/18/2016
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Motor Learning in Stroke
Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke
Status: Enrolling
Updated: 4/18/2016
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
The Hartford Hospital
mi
from
Hartford, CT
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Emory University- Grady Hospital
mi
from
Atlanta, GA
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Emory University- Grady Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
R Cowley Shock Trauma Hospital
mi
from
Baltimore, MD
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
R Cowley Shock Trauma Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Wayne State University/Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Wayne State University - Sinai Grace Hospital
mi
from
Detroit, MI
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Wayne State University - Sinai Grace Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Washington University/Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
Baylor University Medical Center
mi
from
Dallas, TX
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
UT-Houston Health Science Center
mi
from
Houston, TX
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
UT-Houston Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated:  4/18/2016
University of Virginia Medical Center
mi
from
Charlottesville, VA
Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department
Use Of A Point-Of-Care TBI Detection System For Identification Of Head Injured Patients Who Present To The Emergency Department
Status: Enrolling
Updated: 4/18/2016
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
The Hartford Hospital
mi
from
Hartford, CT
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated:  4/18/2016
Emory University- Grady Hospital
mi
from
Atlanta, GA
Validation Of TBI Detection System For Head Injured Patients
Validation Of Point-Of-Care TBI Detection System For Head Injured Patients
Status: Enrolling
Updated: 4/18/2016
Emory University- Grady Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials